David S. Gierada, MD and Lawrence M. Kotner, Jr., MD
Despite strong supportive evidence on and professional society endorsement of CT screening for lung cancer, there is minimal demand from patients or physicians.
Comparative effectiveness research (CER) may become an important factor in Medicare coverage decisions, and the new health care law may make it more easily available to the public to help in medical decision making.
An evidence-based, patient-centered approach is the best way to convince colleagues accustomed to older practice methods of the value of instituting cost-effective screening practices.
How hepatitis C is diagnosed and treated and why treatment of most prisoners with the virus may be safely postponed until after their release from prison.
Dr Noah Boton joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Larnard: “When Should Patients at the End of Life Get Antimicrobials?”